However, it appears MYCN is a conditionally favourable gene in neuroblastomas that do not have MYCN amplification[10,11] and the effect of MYCN expression in neuroblastomas from children of different ages or with disseminated disease may vary[11,12]. The gene discussed is MYCN; the disease is neuroblastoma.